Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three agents—vitamin B12 (cobalamin), folic acid, and nitrous oxide. Vitamin B12 and folic acid are essential water-soluble vitamins involved in DNA synthesis, red blood cell formation, and neurological function. Nitrous oxide is an inhaled anesthetic gas with analgesic properties but also acts as a potent inhibitor of vitamin B12-dependent enzymes. Nitrous oxide oxidizes the cobalt ion in vitamin B12, rendering it inactive; this disrupts methionine synthase activity, leading to impaired methylation reactions critical for myelin maintenance and DNA synthesis[1][3][4]. The resulting functional deficiency can cause megaloblastic anemia and subacute combined degeneration of the spinal cord even if serum B12 levels appear normal[3][4][10]. Folic acid supplementation may be used alongside vitamin B12 to support one-carbon metabolism but does not prevent neurotoxicity from nitrous oxide exposure if functional B12 deficiency persists[3][4]. This combination is not a standard pharmaceutical product or supplement; rather, it represents the interaction between these substances when administered together or encountered concurrently.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin b12 + folic acid + nitrous oxide.